自给自足的Cu2+和H2O协同增强了二硫介导的黑色素瘤化疗
Yingqian Gao1,2, Xiaojun Cai3, Weijuan Zou3
1Department of Ultrasound in Medicine, The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China.
RSC advances
|April 24, 2024
概括
这项研究引入了PVP涂层CuO2纳米点 (CPNDs),以增强对黑色素瘤的双硫 (DSF) 化疗. CPNDs提供控制的铜离子和过氧化释放,促进DSF.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 迪苏尔菲拉姆 (DSF) 通过破坏癌细胞蛋白质降解,显示出作为化疗剂的前景.
- DSF的有效性受到不受控制的铜离子 (Cu2+) /DSF比率的限制.
- 开发优化DSF治疗潜力的策略对于癌症治疗至关重要.
研究的目的:
- 提出一种新的策略,以增强双硫 (DSF) 介导的黑色素瘤化疗.
- 研究自供铜离子和氧化应激对DSF有效性的协同效应.
- 使用PVP涂层CuO2纳米点 (CPNDs) 来改善DSF传递和瘤向.
主要方法:
- 用PVP涂层的CuO2纳米点 (CPNDs) 的合成和表征.
- 研究CPNDs在酸性瘤微环境中产生Cu2+和H2O2的能力.
- 在体外和体内对DSF,Cu2+和H2O2对黑色素瘤细胞的联合作用的评估.
- 分析涉及CuET形成,芬顿类反应和氧化应激的机制.
主要成果:
- 在模拟瘤微环境中,CPNDs成功地产生了足够的Cu2+和H2O2.
- 结合CPNDs和DSF证明了对黑色素瘤的协同抗瘤疗效.
- 增强的疗效是由于改善了CuET的形成,并通过芬顿类反应增加了氧化应激.
- CPND有效控制了Cu2+/DSF比率,最大限度地提高了化疗潜力.
结论:
- 通过提供受控的Cu2+和H2O2来源,CPNDs提供了一种有希望的方法来增强DSF介导的黑色素瘤化疗.
- 这一策略有效地利用铜离子和氧化应激的协同效应,改善抗瘤活性.
- 这些发现表明,一种简单而有效的方法可以优化DSF的化疗疗效,这需要进一步的临床研究.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
8.7K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
